StocksFin Logo
PCRX logo
$PCRX

Pacira BioSciences, Inc.

PCRX country of incorporation
|
https://www.pacira.com
|
Mr. David Stack
|
697 employees
NASDAQ | Healthcare | Drug Manufacturers—Specialty & Generic
PCRX reported its Q322 earnings on November 3, 2022 (96 weeks ago).
$167.47M 31.1% vs. Q321 Revenues Q322
69.74% -4.3% vs. Q321 Gross Profit Margin
-0.41% ! -103% vs. Q321 Net Profit Margin
37.47M -20.6% vs. Q321 Free Cash Flow Q322
$-0.02 ! -105% vs. Q321 EPS Q322
Company Card Q322
As reported on November 3, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q322
As reported on November 3, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
167.47M
-1.1%
50.68M
-693k
-103.5%
$-0.02
Q22022
169.41M
+7.2%
50.63M
19.88M
+191.1%
$0.44
Q12022
157.99M
36.07M
6.83M
$0.15
FY2021
541.53M
 140.26M
41.98M
$0.94
Q42021
159.19M
+24.6%
39.01M
-5.13M
-129%
$-0.12
Q32021
127.72M
-5.8%
34.65M
17.66M
-7.4%
$0.4
Q22021
135.59M
+13.9%
35.25M
19.08M
+84%
$0.43
Q12021
119.03M
31.35M
10.37M
$0.24
FY2020
429.65M
 117.33M
145.52M
$3.41
FY2019
421.03M
 106.71M
-11.02M
$-0.27
FY2018
337.28M
 86.85M
-471k
$-0.01
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
1.73B
 964.24M
109.42M
821.64M
770.12M
Q22022
1.73B
 977.35M
122.06M
831.36M
756.64M
Q12022
1.89B
 1.18B
226.75M
1B
709.58M
FY2021
2.08B
 1.34B
585.58M
1.51B
730.41M
FY2020
1.27B
 654.83M
99.96M
698.2M
619.69M
FY2019
831.07M
 476.12M
78.23M
306.05M
354.94M
FY2018
689.35M
 368.13M
132.53M
291.27M
321.23M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
42.65M
 -47.52M
-7.78M
-5.18M
37.47M
+107.4%
Q22022
29.81M
 19.16M
-153.66M
-11.74M
18.07M
-21.8%
Q12022
30.78M
 -208.02M
-181.59M
-7.67M
23.11M
FY2021
125.72M
 -20.79M
380.69M
-45.87M
79.85M
FY2020
77.03M
 -277.61M
222.3M
-37.8M
39.23M
FY2019
70.52M
 -128.49M
3.67M
-10.16M
60.36M
FY2018
48.87M
 20.58M
8.95M
-14.51M
34.36M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees